Not applicableStudy completedNCT00727753What this trial is testingVEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)Who this might be right forMacular Degeneration University of Zurich 54
Testing effectiveness (Phase 2)Looking for participantsNCT05672121What this trial is testingSafety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)Who this might be right forAge-Related Macular Degeneration Chengdu Origen Biotechnology Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT01189019What this trial is testingHiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular DegenerationWho this might be right forWet Macular DegenerationMacular DegenerationRetinal Pigment Epithelial Detachment Anne Fung MD 40
Large-scale testing (Phase 3)Study completedNCT03834753What this trial is testingA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 228
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636What this trial is testingPivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDWho this might be right forAMDnAMDWet Age-related Macular Degeneration+3 more AbbVie 735
Post-approval studies (Phase 4)Study completedNCT05941715What this trial is testingFaricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Medical University of Graz 70
Post-approval studies (Phase 4)UnknownNCT02810808What this trial is testingSafety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 115
Large-scale testing (Phase 3)Study completedNCT05666804What this trial is testingStudy Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal VasculopathyWho this might be right forMacular Polypoidal Choroidal Vasculopathy (PCV) Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Study completedNCT00733304What this trial is testingAn Extension to Study MD7108240Who this might be right forMacular Degeneration GlaxoSmithKline 42
Large-scale testing (Phase 3)Ended earlyNCT03577899What this trial is testingEfficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)Who this might be right forNeovascular Age-related Macular Degeneration Chengdu Kanghong Biotech Co., Ltd. 1,157
Testing effectiveness (Phase 2)WithdrawnNCT00696592What this trial is testingPhotodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration University of Padova
Testing effectiveness (Phase 2)Study completedNCT00729846What this trial is testingBevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)Who this might be right forAge Related Macular DegenerationChoroidal NeovascularizationMacular Edema California Retina Consultants 22
Early research (Phase 1)Study completedNCT03777254What this trial is testingEvaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration RemeGen Co., Ltd. 12
Not applicableUnknownNCT05831007What this trial is testingSafety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)Who this might be right forNeovascular Age-related Macular Degeneration Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 6
Post-approval studies (Phase 4)Study completedNCT01863199What this trial is testingImpact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)Who this might be right forNeovascular Age Related Macular Degeneration Retinal Consultants of Arizona 60
Early research (Phase 1)Study completedNCT03335852What this trial is testingSafety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMDWho this might be right forMacular Degeneration Allergan 11
Large-scale testing (Phase 3)Study completedNCT01482910What this trial is testingVEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)Who this might be right forMacular Degeneration Bayer 304
Testing effectiveness (Phase 2)Study completedNCT00805233What this trial is testingCombination Ranibizumab and Bromfenac for Neovascular Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Oregon Health and Science University 30
Large-scale testing (Phase 3)Study completedNCT04005352What this trial is testingStudy to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)Who this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 734
Not applicableStudy completedNCT06890026What this trial is testingDurability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD)Treatment-naïve Rigshospitalet, Denmark 742